13 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—April 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces Bryan, Garnier & Co, a leading investment bank focused on growth companies, has initiated research coverage with a buy rating and target price of EUR 17.00 per share. This is a 124% premium to the closing price of EUR 7.60 on April 12, 2022.
13 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—April 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces Lara Smith Weber will join the company as its Chief Financial Officer and Zouhir Mechta will join the company as its Vice President Operations
08 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—April 8, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces that CEO Dave Marver will present at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022 from 10:15-10:55 am EDT.
07 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—April 7, 2022–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces an important publication in the New England Journal of Medicine (NEJM), highlighting the use of ONWARD’s innovative approach to treating orthostatic hypotension in a patient with MSA-P, a degenerative nervous system disease.

Upcoming Events

Recent Presentations